Cite

HARVARD Citation

    Banerjee, S. et al. (n.d.). 2759 Management of nausea and vomiting during treatment with the capsule (CAP) and tablet (TAB) formulations of the PARP inhibitor olaparib. European journal of cancer. pp. S550-. [Online]. 
  
Back to record